Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2005
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2256332C Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/22/2005WO2005121154A1 Process for the preparation of cefdinir
12/22/2005WO2005120508A1 Benzothiazole antiviral agents
12/22/2005WO2005082023A3 Heterocyclic self-immolative linkers and conjugates
12/22/2005WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives
12/22/2005US20050283005 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282873 Epothilone derivative for the treatment of hepatoma and other cancer diseases
12/22/2005US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
12/22/2005US20050282851 antidiabetic agents such as 3-Cyclopentyl-2-(4-methanesulfonyl-phenyl)-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-propionamide, used for prevention and treatment of impaired glucose tolerance, non-insulin dependent diabetes and obesity
12/22/2005US20050282815 Substituted N-(heteroar-beta-yl)aminopyridinecarboxamides or benzamides, e.g., 2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-N-(4-methylthiazol-2-yl)benzamide; glucokinase activators used to treat diabetes mellitus or obesity
12/22/2005US20050282807 Such as (S)-(4-(ethylamino)-2-((4-methylpiperidin-1-yl)methyl)thiazol-5-yl)(2-(methoxymethyl)pyrrolidin-1-yl)methanone; for treatment of neurological and psychiatric disorders/diseases, cancer, and disorders mediated by protein kinase inhibition
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/21/2005EP1607385A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
12/21/2005EP1606351A2 Cyanine dye labelling reagents with meso-substitution
12/21/2005EP1606275A1 Opioid receptor antagonists
12/21/2005EP1606272A1 3-(1-3-(1,3-benzothiazol-6-yl)propylcarbamoyl cycloalkyl)propanoic acid derivatives as nep inhibitors
12/21/2005EP1606271A1 Insecticidal phthalamide derivatives
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711085A Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
12/21/2005CN1709880A AE-active ester chemical synthesizing method
12/21/2005CN1709879A Method for preparing (2)-2-(2-amino-4-thiazole)-2-hydroxy imine acetate and its derivative
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232512C Process for preparing anhydride of aminothiazole derivative
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005105065A3 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
12/15/2005WO2004014313A3 Combination pharmaceutical agents as inhibitors of hcv replication
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277665 e.g. 1,1,1-trifluoro-2-[4-(toluene-2-sulfonyl)phenyl]-propan-2-ol; hydroxysteroid dehydrogenases inhibitor; interconversion between cortisone and cortisol in humans; antidiabetic agent; obesity, insulin resistance, non-insulin -dependent diabetes
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1417189B1 Acylaminothiazole derivatives, their preparation and therapeutic use
12/14/2005EP1227084B1 Drug discharge pump inhibitors
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1200411B1 Process for synthesis of heteroaryl-substituted urea compounds
12/14/2005CN1708487A Tiazol-(bi)cycloalkyl-N-carboxanilides
12/14/2005CN1708486A Novel heterocyclic analogs of diphenylethylene compounds
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1231481C An improved process for the preparation of thiazolidine-2,4-dione derivatives
12/14/2005CN1231475C Process for producing 2-cyanoimino-1, 3-thiazolidine
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974830 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974797 Bactericides for drug resistant bacteria
12/12/2005WO2005121110A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005116001A1 Substituted thiazoleacetic as crth2 ligands
12/08/2005WO2005116000A1 Compounds and compositions as ppar modulators
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115468A1 Novel drug discovery target and medicine acting on the same
12/08/2005WO2005115148A1 3-aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
12/08/2005WO2005097100A3 Antibacterial agents
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272823 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272734 Aids therapy
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272036 Ketones
12/08/2005CA2568742A1 Substituted thiazoleacetic as crth2 ligands
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005CA2563818A1 Compounds and compositions as ppar modulators
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1601460A1 Method for producing bisphenol catalysts and bisphenols
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1064263B1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1230435C Heteroaryl-substd. heterocycles
12/07/2005CN1230416C Pharmaceutical compounds
12/06/2005US6972343 such as N,N'-diformyl-N,N'-di[1-methyl-2-S-thiobenzoyl-4-methoxybut-1-enyl]-1,12-diaminododecane; for treatment of malaria
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/05/2005WO2005116054A1 Process for preparing acyclic hcv protease inhibitors
12/05/2005CA2568008A1 Process for preparing acyclic hcv protease inhibitors
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113490A1 Sulfone-containing prodrugs
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005092871A3 Intermediates for the preparation of pramipexole
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267174 Condensation reagents and a process for their preparation